GUFICBIO

Gufic Biosciences Ltd.

NSE: GUFICBIO

BSE: 509079

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

391.80-2.2 (-0.56%)

23 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

46.4 / 100

Value Score

25.0 / 100

Price Momentum Score

89.8 / 100

QVM Score

54.8 / 100

Key Metrics

Market Cap

3929.09

P/E (TTM)

53.49

P/B

5.91

P/S (TTM)

4.00

EV/EBITDA

25.86

CAPE (5Y)

49.95

ROE (TTM)

10.14

ROCE (TTM)

12.01

ROA (TTM)

5.11

Avg 3Y ROE

14.00

Earnings 3Y CAGR

-3.66

Sales 3Y CAGR

10.85

Sales 5Y CAGR

7.47

Debt/Equity

0.61

Consensus TP

Strong Buy %

Promoter Holding

72.50

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Gufic Biosciences Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 89.8 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

89.8 / 100

Consistently pays dividend

The company has not missed dividend payments once in the last 3 financial years

What is Dividend streak?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 53.49 indicates that the stock is expensive on a standalone basis and is at a 75.55% premium to industry median P/E

What is P/E Ratio?

Median: 30.47

Value 53.49

-0.82614.73

Low dividend yield

The company has a low dividend yield of 0.03%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 47.4 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

47.4 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Gufic Biosciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Gufic Biosciences Ltd. Shareholding Pattern

Quarterly breakdown of Gufic Biosciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Promoter	65.75	65.75	65.75	65.75	65.75	65.13	75.48	75.48	75.48	75.00	75.00	75.00	75.00	75.00	75.00	72.51	72.51	72.50	72.51	72.51	72.51	72.52	72.50	72.50	72.50	72.50	72.50
Indian Promoter	65.75	65.75	65.75	65.75	65.75	65.13	75.48	75.48	75.48	75.00	75.00	75.00	75.00	75.00	75.00	72.51	72.51	72.50	72.51	72.51	72.51	72.52	72.50	72.50	72.50	72.50	72.50
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	9.52	8.58	8.79	9.04	8.47	3.38	3.65	2.88	2.63	2.51	1.22	1.32	1.88	1.86	2.36	2.20	2.32	2.61	2.74	3.28	3.70	3.70	3.99	4.18	4.25	4.14	3.83
Mutual Funds / UTI	7.80	7.91	8.72	8.70	8.24	3.24	2.13	1.19	1.03	1.03	1.03	1.03	1.03	1.03	1.50	1.60	2.08	2.30	2.51	2.92	3.39	3.38	3.48	3.53	3.63	3.43	3.03
FI/Bank/Insurance	0.08	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.59	0.59	0.06	0.33	0.23	0.14	1.52	1.69	1.51	1.38	0.06	0.16	0.72	0.70	0.72	0.47	0.12	0.23	0.23	0.30	0.31	0.32	0.33	0.44	0.42	0.47	0.44
Other Institutions	1.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.10	0.13	0.13	0.13	0.13	0.14	0.12	0.12	0.08	0.00	0.07	0.00	0.00	0.18	0.21	0.20	0.24	0.35
Non-Institution	24.73	25.67	25.46	25.21	25.77	31.49	20.87	21.64	21.89	22.49	23.78	23.69	23.12	23.14	22.64	25.29	25.18	24.88	24.74	24.21	23.79	23.78	23.51	23.32	23.25	23.36	23.67
Bodies Corporate	2.77	2.89	1.72	2.20	2.05	1.41	1.47	0.92	0.90	1.32	1.36	1.27	1.10	1.09	1.41	4.50	4.49	4.73	4.96	4.97	4.91	4.92	1.99	2.18	2.30	2.31	3.10
Others (incl. Retail) No. of shareholders	21.96 15,376	22.78 16,376	23.74 20,129	23.01 17,982	23.72 19,494	30.08 43,689	19.40 34,943	20.72 34,374	20.99 37,938	21.17 39,887	22.42 41,148	22.42 40,326	22.02 38,674	22.05 38,405	21.23 36,331	20.79 34,201	20.69 34,478	20.15 32,030	19.78 32,597	19.24 33,075	18.88 31,627	18.86 31,670	21.52 31,220	21.14 30,164	20.95 29,035	21.05 29,555	20.57 29,498

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Gufic Biosciences Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Gufic Biosciences Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
JAYESH CHOKSI Promoter & Director	June-2022	Market Sale (Disposal) 3rd Jun 2022	25.49 %	₹ 220.43	18.00 k	₹ 39.68 lac
JAYESH CHOKSI Promoter & Director	June-2022	Market Sale (Disposal) 3rd Jun 2022	25.95 %	₹ 217.65	4.50 lac	₹ 9.79 cr

Corporate Actions

History of Gufic Biosciences Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.10/share
Record date: 28th Aug 2026Ex-date: 28th Aug 2026
Announced on: 30th May 2026
Dividend₹ 0.10/share
Record date: 22nd Sep 2025Ex-date: 22nd Sep 2025
Announced on: 30th May 2025
Dividend₹ 0.10/share
Record date: 18th Sep 2024Ex-date: 17th Sep 2024
Announced on: 29th May 2024
Dividend₹ 0.10/share
Record date: 21st Sep 2023Ex-date: 21st Sep 2023
Announced on: 29th May 2023
Dividend₹ 0.10/share
Record date: 25th Aug 2022Ex-date: 24th Aug 2022
Announced on: 20th May 2022

Company Profile

Overview of Gufic Biosciences Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Gufic Biosciences Limited is an India-based company, which is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates in the pharmaceutical segment. It has pharmaceutical products under categories, such as Cr...

Key personnel

Mr. Devkinandan B. Roonghta

Chief Financial Officer

Ms. Ami Naresh Shah

Compliance Officer, Company Secretary

Mr. Jayesh P. ChoksiD

Executive Chairman of the Board, Managing Director

Mr. Pranav J. ChoksiD

Chief Executive Officer, Whole Time Director

Mr. Pankaj J. GandhiD

Whole Time Director

Dr. Anu Sanjiv AuroraD

Non-Executive Independent Director

Mr. Akshya Kumar MahapatraD

Non-Executive Independent Director

Mr. Kamal Kishore SethD

Additional Non-Executive Independent Director

View all

Incorporated on

23 Jul 1984

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

1,607

IPO date

19 Oct 2004

Free Float

2,25,67,719

Website

https://gufic.com/

Phone no.

+912267261000

Address

1ST TO 4TH FLOOR, SM HOUSE 11, SHAKAR ROAD,, VILE PARLE (EAST), , 400057, India

Frequently Asked Questions

What is the current share price of Gufic Biosciences Ltd.?

The current share price of Gufic Biosciences Ltd. is ₹ 391.80 as of 23 Oct 2026.

What is the market capitalisation of Gufic Biosciences Ltd.?

The market capitalisation of Gufic Biosciences Ltd. stands at ₹ 3,929.09 Cr.

What is the PE ratio of Gufic Biosciences Ltd.?

The Price-to-Earnings (PE) ratio of Gufic Biosciences Ltd. is 53.49 as of the latest trailing twelve months data.

What is the ROE and ROCE of Gufic Biosciences Ltd.?

Gufic Biosciences Ltd. has a Return on Equity (ROE) of 10.14% and a Return on Capital Employed (ROCE) of 12.01% as per the latest financial reports.

What is the 52-week high and low of Gufic Biosciences Ltd.?

The 52-week high of Gufic Biosciences Ltd. is - and the 52-week low is -.

What is the dividend yield of Gufic Biosciences Ltd.?

The dividend yield of Gufic Biosciences Ltd. is 0.03% based on the current market price.

What is the FII and DII holding in Gufic Biosciences Ltd.?

Foreign Institutional Investors (FII) hold 0.44%, Domestic Institutional Investors (DII) hold 3.03% and retail/public investors hold 20.57% of Gufic Biosciences Ltd. shares.

What sector does Gufic Biosciences Ltd. belong to?

Gufic Biosciences Ltd. operates in the Healthcare sector.

What is the beta of Gufic Biosciences Ltd.?

The beta of Gufic Biosciences Ltd. is 0.63, indicating its price volatility relative to the broader market. Over the past 1 year, Gufic Biosciences Ltd. has delivered an absolute return of 7.98%.

What is the RSI of Gufic Biosciences Ltd.?

The 14-day Relative Strength Index (RSI) of Gufic Biosciences Ltd. is 37.91, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Gufic Biosciences Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Gufic Biosciences Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile

Corporate Actions